Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Login

Scholar Register

Business Register

Subscribe

Citation(s) in RCA

2
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For:	Johansen-Bibby A. Prescribing for pregnancy: epilepsy. Drug Ther Bull 2020;58:103-106. [PMID: 32503804 DOI: 10.1136/dtb.2019.000009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]

Number	Cited by Other Article(s)
1	Safety update: pregabalin during pregnancy. Drug Ther Bull 2022;60:117. [PMID: 35902098 DOI: 10.1136/dtb.2022.000037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023] Abstract Overview of: Medicines and Healthcare products Regulatory Agency. Pregabalin (Lyrica): findings of safety study on risks during pregnancy. Drug Safety Update 2022;15(9):2-6. Collapse Key Words Drug-Related Side Effects and Adverse Reactions Health Care Quality, Access, and Evaluation Collapse MESH Headings Female Humans Pregabalin/adverse effects Pregnancy Collapse Grants Collapse Affiliation(s) Collapse
2	Antiepileptic drugs in pregnancy. Drug Ther Bull 2021;59:99. [PMID: 33832945 DOI: 10.1136/dtb.2021.000018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Abstract Overview of: Medicines and Healthcare products Regulatory Agency. Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review. Drug Safety Update 2021;14(6):1. Collapse Key Words access and evaluation drug-related side effects and adverse reactions health care quality Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA